Jyothy Laboratories reported a net sales of Rs 384.79 crore for the quarter ended December 31st, 2015 as against Rs 356.37 crore for the corresponding quarter last year, a rise of 8 percent. During the same period, the company reported a Net Profit of Rs 38.99 crore, as against Rs 26.46 crore; up by 47.4 percent.
The EBIDTA margin for the quarter was at 13.9 percent as against 13.5 percent reported in Q3FY15. The company reported EPS of Rs 2.15 as against Rs 1.46 in the corresponding quarter last year.
For the nine months period, JLL reported Net Sales of Rs 1,199.52 crore compared to Rs 1,109.18 crore during the corresponding period last year, a rise of 8.1 percent. Net Profit for 9MFY16 stood at Rs 122.34 crore compared to Rs 94.06 crore; up 30.1 percent.
The EBIDTA margin for the nine months period ended December 31st, 2015 was at 14.8 percent as against 12.6 percent reported in 9MFY15. The company reported EPS of Rs 6.75 as against Rs 5.20 of previous year.
MP Ramachandran, Chairman & Managing Director, Jyothy Laboratories, said, “Q3FY16 has been a good quarter for us. With increased investment in our brands and differentiated product offering we are well poised to strengthen our position in the market. The next year is expected to see a host of brand activities from the house of Ujala. We will also continue to invest in our power brands to improve consumer mindshare and capitalise on our new offerings. We are very confident that in the coming quarters, a gradual pick up in the consumer demand along with an overall improvement in the country’s economy will further aid in improving performance of the company.”